Table 4 Correlation of peak data to clinical data
From: Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra
Δ peak intensity (Da) | Significant correlations (p < 0.05) |
|---|---|
Significant correlations in changes from baseline to 13Â weeks | |
 2,740 | Δ IL-6, Δ fasting insulin |
 7,048 | Δ CRP |
 13,752 | Δ IL-6, Δ CRP |
 13,944 | Δ CRP |
 14,089 | Δ IL-6, Δ CRP, Δ fasting insulin |
 14,300 | Δ IL-6, Δ CRP |
 14,507 | Δ IL-6, Δ CRP |
 14,758 | Δ IL-6, Δ CRP |
 27,788 | Δ IL-6, Δ CRP |
 39,866 | Δ C-peptide iv OGTT, Δ C-peptide total OGTT |
 56,878 | Δ IL-6, Δ CRP, Δ fasting insulin |
 79,628 | – |
 7,042 | Δ CRP, Δ FFA |
 8,208 | Δ triglycerides, Δ cholesterol |
 20,990 | Δ IL-6, Δ CRP |
 21,086 | Δ IL-6, Δ CRP, Δ fasting insulin, Δ iv insulin, Δ 120 min plasma glucose |
 21,278 | Δ IL-6, Δ CRP, Δ fasting insulin |
 28,601 | Δ IL-6, Δ CRP |
Significant correlations at baseline | |
 5,898 | FFA, HDL, CRP |
 6,663 | – |
 8,741 | FFA, triglycerides |
 50,123 | LDL, triglycerides, cholesterol, blood glucose |